Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AMGEN INC | 180,547 | reported | 25 Apr 2014 | tx 83+158,748.03−210,212 |
| OccuLogix, Inc. | 85,000 | reported | 03 Jul 2007 | tx 5+112,500 |
| GALECTIN THERAPEUTICS INC | 60,000 | reported | 16 Jan 2026 | tx 21+746,132−47,693 |
| Amesite Inc. | 50,000 | reported | 31 Mar 2020 | tx 2+60,000 |
| Elicio Therapeutics, Inc. |
| 15,000 |
| reported |
| 09 Jun 2022 |
| tx 8+91,657 |
| Esperion Therapeutics, Inc. | 14,000 | reported | 17 Apr 2017 | tx 7+61,000 |
| Amesite Inc. | 0 | reported | 07 Mar 2026 | tx 33+789,737−92,572 |
| ROHM & HAAS CO | 0 | reported | 01 Apr 2009 | tx 38+10,026.653−51,009.14 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Mar 2026 | EXERCISE | Amesite Inc. | 41,322 | — | |
| 07 Mar 2026 | EXERCISE | Amesite Inc. | 41,322 | 0.00 USD | deriv |
| 06 Feb 2026 | GRANT_AWARD | Amesite Inc. | 49,751 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Amesite Inc. | 6,349 | 0.00 USD | deriv |
| 30 Sept 2025 | GRANT_AWARD | Amesite Inc. | 3,934 | 0.00 USD | deriv |
| 30 Jun 2025 | GRANT_AWARD | Amesite Inc. | 4,461 | 0.00 USD | deriv |
| 31 Mar 2025 | GRANT_AWARD | Amesite Inc. | 4,959 | 0.00 USD | deriv |
| 07 Mar 2025 | GRANT_AWARD | Amesite Inc. | 41,322 | — | |
| 31 Mar 2023 | EXERCISE | Amesite Inc. | 14,620 | — | |
| 07 Mar 2025 | GRANT_AWARD | Amesite Inc. | 41,322 | 0.00 USD | deriv |
| 31 Mar 2023 | EXERCISE | Amesite Inc. | 14,620 | 0.00 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 23 Jan 2025 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 60,000 | 0.00 USD | deriv |
| 16 Jan 2025 | EXERCISE | Amesite Inc. | 36,630 | — | |
| 16 Jan 2025 | EXERCISE | Amesite Inc. | 36,630 | 0.00 USD | deriv |
| 07 Jan 2025 | PURCHASE | Amesite Inc. | 3,333 | 3.00 USD | first after silence |
| 31 Dec 2024 | GRANT_AWARD | Amesite Inc. | 2,526 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Amesite Inc. | 4,898 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Amesite Inc. | 4,000 | 0.00 USD | deriv |
| 28 Mar 2024 | GRANT_AWARD | Amesite Inc. | 5,381 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | GALECTIN THERAPEUTICS INC | 50,000 | 0.00 USD | deriv |
| 16 Jan 2024 | GRANT_AWARD | Amesite Inc. | 36,630 | 0.00 USD | deriv |
| 29 Dec 2023 | GRANT_AWARD | Amesite Inc. | 5,333 | 0.00 USD | deriv |
| 29 Sept 2023 | GRANT_AWARD | Amesite Inc. | 4,706 | 0.00 USD | deriv |
6 purchases reported after at least 12 months of silence — most recent on 07 Jan 2025.